NO20081809L - Glukuronatsalt av en piperazinforbindelse - Google Patents
Glukuronatsalt av en piperazinforbindelseInfo
- Publication number
- NO20081809L NO20081809L NO20081809A NO20081809A NO20081809L NO 20081809 L NO20081809 L NO 20081809L NO 20081809 A NO20081809 A NO 20081809A NO 20081809 A NO20081809 A NO 20081809A NO 20081809 L NO20081809 L NO 20081809L
- Authority
- NO
- Norway
- Prior art keywords
- piperazine compound
- glucuronate salt
- salt form
- salt
- glucuronate
- Prior art date
Links
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical class OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 title abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- -1 piperazine compound Chemical class 0.000 title 1
- 150000003839 salts Chemical group 0.000 abstract 2
- SDAMYSWGWHXMRT-UHFFFAOYSA-N 8-[4-[3-(5-fluoro-1h-indol-3-yl)propyl]piperazin-1-yl]-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(F)C=C2C(CCCN3CCN(CC3)C3=CC=CC4=C3OC(C(N4)=O)C)=CNC2=C1 SDAMYSWGWHXMRT-UHFFFAOYSA-N 0.000 abstract 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71616705P | 2005-09-12 | 2005-09-12 | |
| PCT/US2006/035517 WO2007033191A1 (en) | 2005-09-12 | 2006-09-12 | Glucuronate salt of a piperazine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081809L true NO20081809L (no) | 2008-04-14 |
Family
ID=37603202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081809A NO20081809L (no) | 2005-09-12 | 2008-04-14 | Glukuronatsalt av en piperazinforbindelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7595310B2 (pt) |
| EP (1) | EP1940830A1 (pt) |
| JP (1) | JP2009507921A (pt) |
| KR (1) | KR20080045285A (pt) |
| CN (1) | CN101287730B (pt) |
| AR (1) | AR056506A1 (pt) |
| AU (1) | AU2006291058B2 (pt) |
| BR (1) | BRPI0615853A2 (pt) |
| CA (1) | CA2620755A1 (pt) |
| EA (1) | EA014942B1 (pt) |
| GT (1) | GT200600414A (pt) |
| IL (1) | IL189809A0 (pt) |
| MY (1) | MY144782A (pt) |
| NO (1) | NO20081809L (pt) |
| PE (1) | PE20070433A1 (pt) |
| SA (1) | SA06270329B1 (pt) |
| TW (1) | TW200800974A (pt) |
| UA (1) | UA95922C2 (pt) |
| WO (1) | WO2007033191A1 (pt) |
| ZA (1) | ZA200802310B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| AR055424A1 (es) | 2005-09-12 | 2007-08-22 | Wyeth Corp | Formulacion de liberacion sostenida y usos de la misma |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| EP2155200B1 (en) | 2007-05-11 | 2016-12-07 | Richter Gedeon Nyrt. | Crystalline form of a carbamoyl-cyclohexane derivative |
| HUP0700353A2 (en) | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| RS53866B1 (sr) | 2008-07-16 | 2015-08-31 | Richter Gedeon Nyrt. | Farmaceutske formulacije koje sadrže ligande dopaminskih receptora |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| US8912197B2 (en) | 2012-08-20 | 2014-12-16 | Forest Laboratories Holdings Ltd. | Crystalline form of carbamoyl-cyclohexane derivatives |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438119A (en) * | 1982-12-23 | 1984-03-20 | Mead Johnson & Company | Method for alleviation of extrapyramidal motor disorders |
| US4687772A (en) * | 1986-10-07 | 1987-08-18 | Bristol-Myers Company | Method for improvement of short term memory |
| US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
| US5162375A (en) * | 1988-05-06 | 1992-11-10 | Beecham Group P.L.C. | Treatment of neuronal degeneration with 5HT1A agonists |
| US5824680A (en) * | 1991-08-31 | 1998-10-20 | Bayer Aktiengesellschaft | Ipsapirone for the treatment of alzheimer's disease by improving memory |
| DE4135551A1 (de) | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
| US5716960A (en) * | 1995-01-13 | 1998-02-10 | U.S. Bioscience Inc. And Individuals | Crystalline trimetrexate salts and the process for making the same |
| SE9900190D0 (sv) | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
| DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| KR100545329B1 (ko) * | 1997-07-25 | 2006-01-24 | 하. 룬트벡 아크티에 셀스카브 | 인돌 및 2,3-디히드로인돌 유도체, 그들의 제조방법 및 사용 |
| HN1999000146A (es) | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
| WO2001014330A2 (en) * | 1999-08-23 | 2001-03-01 | Solvay Pharmaceuticals B.V. | Phenylpiperazines as serotonin reuptake inhibitors |
| AU780817B2 (en) | 2000-01-19 | 2005-04-21 | Akzo Nobel N.V. | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| AU2004266233A1 (en) * | 2003-08-13 | 2005-03-03 | Amgen, Inc. | Melanin concentrating hormone receptor antagonist |
| EP1592688A2 (en) | 2003-12-18 | 2005-11-09 | Teva Pharmaceutical Industries Ltd. | Polymorphic form b2 of ziprasidone base |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| AR055424A1 (es) | 2005-09-12 | 2007-08-22 | Wyeth Corp | Formulacion de liberacion sostenida y usos de la misma |
| GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina |
-
2006
- 2006-09-08 GT GT200600414A patent/GT200600414A/es unknown
- 2006-09-11 AR ARP060103944A patent/AR056506A1/es not_active Application Discontinuation
- 2006-09-11 TW TW095133454A patent/TW200800974A/zh unknown
- 2006-09-11 PE PE2006001091A patent/PE20070433A1/es not_active Application Discontinuation
- 2006-09-12 CN CN2006800382372A patent/CN101287730B/zh not_active Expired - Fee Related
- 2006-09-12 KR KR1020087008818A patent/KR20080045285A/ko not_active Ceased
- 2006-09-12 JP JP2008531254A patent/JP2009507921A/ja active Pending
- 2006-09-12 AU AU2006291058A patent/AU2006291058B2/en not_active Ceased
- 2006-09-12 US US11/519,756 patent/US7595310B2/en not_active Expired - Fee Related
- 2006-09-12 EA EA200800810A patent/EA014942B1/ru not_active IP Right Cessation
- 2006-09-12 SA SA06270329A patent/SA06270329B1/ar unknown
- 2006-09-12 WO PCT/US2006/035517 patent/WO2007033191A1/en not_active Ceased
- 2006-09-12 MY MYPI20080551A patent/MY144782A/en unknown
- 2006-09-12 CA CA002620755A patent/CA2620755A1/en not_active Abandoned
- 2006-09-12 EP EP06803440A patent/EP1940830A1/en not_active Withdrawn
- 2006-09-12 BR BRPI0615853-6A patent/BRPI0615853A2/pt not_active IP Right Cessation
- 2006-12-09 UA UAA200804630A patent/UA95922C2/ru unknown
-
2008
- 2008-02-27 IL IL189809A patent/IL189809A0/en unknown
- 2008-03-11 ZA ZA200802310A patent/ZA200802310B/xx unknown
- 2008-04-14 NO NO20081809A patent/NO20081809L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY144782A (en) | 2011-11-15 |
| CA2620755A1 (en) | 2007-03-22 |
| EP1940830A1 (en) | 2008-07-09 |
| CN101287730A (zh) | 2008-10-15 |
| GT200600414A (es) | 2007-09-20 |
| US7595310B2 (en) | 2009-09-29 |
| BRPI0615853A2 (pt) | 2011-05-31 |
| PE20070433A1 (es) | 2007-04-24 |
| ZA200802310B (en) | 2008-12-31 |
| KR20080045285A (ko) | 2008-05-22 |
| US20070254876A1 (en) | 2007-11-01 |
| EA200800810A1 (ru) | 2008-10-30 |
| AR056506A1 (es) | 2007-10-10 |
| UA95922C2 (en) | 2011-09-26 |
| AU2006291058A1 (en) | 2007-03-22 |
| SA06270329B1 (ar) | 2010-06-15 |
| CN101287730B (zh) | 2012-03-07 |
| WO2007033191A1 (en) | 2007-03-22 |
| TW200800974A (en) | 2008-01-01 |
| EA014942B1 (ru) | 2011-04-29 |
| IL189809A0 (en) | 2008-08-07 |
| JP2009507921A (ja) | 2009-02-26 |
| AU2006291058B2 (en) | 2011-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081809L (no) | Glukuronatsalt av en piperazinforbindelse | |
| NO20034011D0 (no) | Steroider som agonister for FXR | |
| WO2008006044A3 (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
| BRPI0508098A (pt) | compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos | |
| CY1113029T1 (el) | Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
| TW200801814A (en) | Positive resist composition and pattern formation method using the same | |
| CA2492096A1 (en) | Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides | |
| CY1112201T1 (el) | Φαρμακο για τη θεραπευτικη αγωγη γριπης | |
| CL2008003684A1 (es) | Composicion farmaceutica que comprende una sal de aluminio, que tiene una relacion molar de aluminio a cloruro de 0,3:1 a 3:1 aproximadamente, ademas comprende zirconio; metodo de preparacion de la composicion; uso como antitranspirante. | |
| WO2005074642A3 (en) | Chemical compounds | |
| TW200531683A (en) | Aryl- and heteroarylpiperidinecarboxylate derivatives, their preparation and their application in therapeutics | |
| BRPI0621446C1 (pt) | composição farmacêutica para uso externo | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| NO20071707L (no) | Fremstilling av 4,5-dihydro-pyrazolo[3,4-C]Pyrid-2-oner | |
| ECSP045221A (es) | Sales de valsartan | |
| NO20076680L (no) | Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter | |
| DK1611144T3 (da) | Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister | |
| WO2008149834A1 (ja) | ピリミドジアゼピノン誘導体 | |
| NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
| NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
| GB2429206A (en) | Process for the synthesis of hydromorphone | |
| AU2003294092A1 (en) | Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics | |
| BRPI0719529B8 (pt) | método para produzir uma preparação sólida | |
| WO2006021559A3 (de) | Verfahren zur herstellung von tiotropiumsalzen und silicium-derivate als zwischenprodukte | |
| UA106191C2 (ru) | Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |